Page 31 - Molecule Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021 News provided by Share this article Share this article ResearchAndMarkets.com's offering. Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action o...

Saudi Arabia Pharmaceutical Drugs Market to Surpass US$ 16,663.1 Million by 2027, Says Coherent Market Insights (CMI) April 23, 2021 08:30 ET | Source: CMI CMI Pune, INDIA SEATTLE, April 23, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Saudi Arabia pharmaceutical drugs market is estimated to be valued at US$ 7.3 Key Trends and Analysis of the Key trends in the market include increasing partnership strategies, product launches and approvals, and others. The major pharmaceutical manufacturers in Saudi Arabia are focused on...

Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON, UK, April 7, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The companies operating in the biosimilars industry are continuously focusing on new product development in collaborations with other companies operatin...

Interleukin Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Interleukin Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON , UK, April 6, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports Patent expiry of biologic drugs is opening opportunities for biosimilar drugs, which are a cheap alternative and thus among interleukin inhibitors ma...

Share this article Share this article ResearchAndMarkets.com's offering. Since the approval of Vitravene (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development. Examples of recently approved antisense therapeutics include (in reverse chronological order) Viltepso (duchenne muscular dystrophy, March 2020), Vyondys 53 (duchenne muscular dystrophy, December 2019) and ...